Founded in 2017 as a subsidiary of CSPC Pharmaceutical Company Ltd. (CSPC), Conjupro Biotherapeutics, Inc., is a leading biopharmaceutical company based in Princeton, NJ. With a dedicated team of medical, regulatory and clinical experts, the company focuses on clinical research and drug development for treating Oncology, Cardiology, and CNS diseases.

At Conjupro, we adhere to the mission set forth by our parent company, CSPC, and we believe it is our responsibility to conduct research and development for drugs that put people first, with the goal of improving health. Our corporate culture values honesty and excellence, along with fairness, benevolence, diligence, and altruism.

We ensure that we are creating the best working environment for our staff members by offering them the respect and trust that they deserve.